Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Contrafect patents

List of Contrafect patents

List of Paragon Airheater Technologies patents

List of Thomas Jefferson University patents

List of Bonumose patents

List of mobile commerce companies

List of companies in AdInvest's investment portfolio

Patents where

Current Assignee

Name

is

Contrafect

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11357833 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby		Contrafect	Contrafect		United States Patent and Trademark Office	11357833	June 14, 2022
	‌ US Patent 11524046 Biofilm prevention, disruption and treatment with bacteriophage lysin	Patent 11524046 was granted and assigned to Contrafect on December, 2022 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	11524046	December 13, 2022
	‌ US Patent 11413334 Lysin polypeptides active against Gram-negative bacteria	Patent 11413334 was granted and assigned to Contrafect on August, 2022 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	11413334	August 16, 2022
	‌ US Patent 9889181 Bacteriophage lysin and antibiotic combinations against gram positive bacteria	Patent 9889181 was granted and assigned to Contrafect on February, 2018 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	9889181	February 13, 2018
	‌ US Patent 10988520 Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof	Patent 10988520 was granted and assigned to Contrafect on April, 2021 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	10988520	April 27, 2021
	‌ US Patent 9499594 Biofilm prevention, disruption and treatment with bacteriophage lysin	Patent 9499594 was granted and assigned to Contrafect on November, 2016 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	9499594	November 22, 2016
	‌ US Patent 10744189 Lysin polypeptides active against Gram-negative bacteria	Patent 10744189 was granted and assigned to Contrafect on August, 2020 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	10744189	August 18, 2020
	‌ US Patent 10851401 Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides		Contrafect	Contrafect		United States Patent and Trademark Office	10851401	December 1, 2020
	‌ US Patent 10813983 Bacteriophage lysin and antibiotic combinations against gram positive bacteria	Patent 10813983 was granted and assigned to Contrafect on October, 2020 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	10813983	October 27, 2020
	‌ US Patent 9718875 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy	Patent 9718875 was granted and assigned to Contrafect on August, 2017 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	9718875	August 1, 2017
	‌ US Patent 11773140 Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum	Patent 11773140 was granted and assigned to Contrafect on October, 2023 by the United States Patent and Trademark Office.	Contrafect	Contrafect		United States Patent and Trademark Office	11773140	October 3, 2023

11 results

0 selected

11 results

0 selected